• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
AGN 2.56% 60.0¢

ARGENICA THERAPEUTICS LIMITED - Corporate Spotlight

Argenica Therapeutics Limited is an Australia-based clinical drug development company.... Argenica Therapeutics Limited is an Australia-based clinical drug development company. The Company is focused on developing therapeutics to reduce brain tissue death after stroke and other types of brain injury and neurodegenerative diseases to improve patient outcomes. The Company's lead candidate, ARG-007, is a cationic arginine-rich peptide that aims to protect brain cells and reduce cell death following a stroke, and other types of neural injury, in order to minimize the impact of these conditions and improve patient recovery. ARG-007 has been successfully demonstrated to improve outcomes in pre-clinical stroke models, traumatic brain injury (TBI) and hypoxic ischaemic encephalopathy (HIE). More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

No Corporate Spotlight currently available.

(20min delay)
Last
60.0¢
Change
0.015(2.56%)
Mkt cap ! $73.07M
Open High Low Value Volume
60.0¢ 61.5¢ 59.0¢ $66.21K 110.6K

Buyers (Bids)

No. Vol. Price($)
1 5000 59.5¢
 

Sellers (Offers)

Price($) Vol. No.
60.0¢ 4943 1
View Market Depth
Last trade - 15.26pm 06/05/2024 (20 minute delay) ?
Last
60.5¢
  Change
0.015 ( 4.31 %)
Open High Low Volume
59.0¢ 61.0¢ 59.0¢ 61277
Last updated 15.23pm 06/05/2024 ?
AGN (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.